Risk factors associated with post-transplant superior caval vein stenosis in paediatric heart transplantation

Hanna J Tadros1, Joseph T Whelihan1, Dalia Lopez-Colon1

  • 1Congenital Heart Center, Department of Pediatrics, University of Florida, Gainesville, FL, USA.

Cardiology in the Young
|February 24, 2021
PubMed

Insights

Superior caval vein stenosis affects nearly 30% of pediatric heart transplant recipients. Factors like prior surgeries and smaller patient size increase stenosis risk, sometimes requiring intervention.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Transplantation Medicine

Background:

  • Superior caval vein stenosis is a recognized complication after pediatric heart transplantation.
  • Understanding its incidence and risk factors is crucial for patient management.

Purpose of the Study:

  • To determine the incidence of superior caval vein stenosis post-pediatric heart transplantation.
  • To identify variables associated with stenosis development and the need for intervention.

Main Methods:

  • Retrospective review of 204 pediatric heart transplant recipients.
  • Identification of stenosis via angiographic and echocardiographic findings.
  • Analysis of patient characteristics and surgical history.

Main Results:

  • 24.0% experienced stenosis without intervention; 5.9% required intervention.
  • Stenosis was linked to cavopulmonary anastomosis, prior superior caval vein procedures, and bicaval technique.
  • Smaller recipients/donors and younger age at diagnosis correlated with intervention need.

Conclusions:

  • Superior caval vein stenosis is a significant complication in pediatric heart transplantation.
  • Specific surgical approaches and patient factors influence stenosis risk and intervention requirements.
  • Early identification and management are key for favorable outcomes.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
151
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
144
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
144